Literature DB >> 8462804

Arteriovenous shunting, hemodynamic changes, and renal sodium retention in liver cirrhosis.

C M Fernández-Rodriguez1, J Prieto, J M Zozaya, J Quiroga, R Guitián.   

Abstract

BACKGROUND: Arterial vasodilation has been postulated to initiate sodium retention in cirrhosis. This work was designed to analyze whether arteriovenous shunting underlies vasodilation and influences renal function in cirrhosis.
METHODS: The femoral arteriovenous difference in oxygen content (Ca-VO2) was measured in 10 healthy subjects (control group) and 31 cirrhotic patients: 9 without ascites (group 1), 10 with ascites and a urinary sodium excretion rate (UNaV) of > 10 mEq/24 h (group 2), and 12 with ascites and UNaV of < or = 10 mEq/24 h (group 3). In 8 subjects from each group, femoral blood flow and the cardiac output were determined by duplex-Doppler ultrasonography. In 9 cases arteriovenous shunting in the femoral territory was estimated using 30 +/- 5-microns radiolabeled microspheres.
RESULTS: Ca-VO2 was lower in group 3 than in controls or group 1. Ca-VO2 correlated inversely with femoral blood flow, plasma renin activity, plasma aldosterone concentration, and degree of shunting measured by microspheres. Ca-VO2 correlated directly with systemic vascular resistance and prothrombin index.
CONCLUSIONS: In decompensated cirrhotic patients, there is an increased arteriovenous shunt for oxygen in the lower extremities that is associated with increased arterial blood flow, decreased systemic vascular resistance, and worsening of liver function. This shunt is due partly to opening of arteriovenous precapillary connections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8462804     DOI: 10.1016/0016-5085(93)90285-k

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.

Authors:  G Nasr; A Hassan; S Ahmed; A Serwah
Journal:  J Cardiovasc Dis Res       Date:  2010-07

Review 2.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

3.  Enhanced urinary excretion of cGMP in liver cirrhosis. Relationship to hemodynamic changes, neurohormonal activation, and urinary sodium excretion.

Authors:  C M Fernández-Rodriguez; J Prieto; J Quiroga; J M Zozaya; A Andrade; C Rodriguez-Ortigosa
Journal:  Dig Dis Sci       Date:  1997-07       Impact factor: 3.199

4.  Outcome of hepatectomy for hepatocellular carcinoma in patients with renal dysfunction.

Authors:  Takeo Toshima; Ken Shirabe; Shohei Yoshiya; Jun Muto; Toru Ikegami; Tomoharu Yoshizumi; Yoshihiko Maehara
Journal:  HPB (Oxford)       Date:  2012-05       Impact factor: 3.647

5.  Hemodynamics in the immediate post-transplantation period in alcoholic and viral cirrhosis.

Authors:  Waleed K Al-Hamoudi; Saleh Alqahtani; Puneeta Tandon; Mang Ma; Samuel S Lee
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

Review 6.  The hepatorenal syndrome.

Authors:  G Van Roey; K Moore
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

7.  Low systemic vascular resistance: differential diagnosis and outcome.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

8.  Alterations in arterial blood parameters in patients with liver cirrhosis and ascites.

Authors:  Konstantinos Charalabopoulos; Dimitrios Peschos; Leonidas Zoganas; George Bablekos; Christos Golias; Alexander Charalabopoulos; Dimitrios Stagikas; Angi Karakosta; Athanasios Papathanasopoulos; George Karachalios; Anna Batistatou
Journal:  Int J Med Sci       Date:  2007-03-06       Impact factor: 3.738

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.